Inhibition of Oxidative Phosphorylation Reverses Bone Marrow Hypoxia Visualized in Imageable Syngeneic B-ALL Mouse Model.

Frontiers in Oncology
Mateusz RytelewskiMarina Konopleva

Abstract

Abnormally low level of interstitial oxygen, or hypoxia, is a hallmark of tumor microenvironment and a known promoter of cancer chemoresistance. Inside a solid tumor mass, the hypoxia stems largely from inadequate supply of oxygenated blood through sparse or misshapen tumor vasculature whilst oxygen utilization rates are low in typical tumor's glycolytic metabolism. In acute leukemias, however, markers of intracellular hypoxia such as increased pimonidazole adduct staining and HIF-1α stabilization are observed in advanced leukemic bone marrows (BM) despite an increase in BM vasculogenesis. We utilized intravital fast scanning two-photon phosphorescence lifetime imaging microscopy (FaST-PLIM) in a BCR-ABL B-ALL mouse model to image the extracellular oxygen concentrations (pO2) in leukemic BM, and we related the extracellular oxygen levels to intracellular hypoxia, vascular markers and local leukemia burden. We observed a transient increase in BM pO2 in initial disease stages with intermediate leukemia BM burden, which correlated with an expansion of blood-carrying vascular network in the BM. Yet, we also observed increased formation of intracellular pimonidazole adducts in leukemic BM at the same time. This intermediate stage wa...Continue Reading

References

Mar 15, 1997·Nucleic Acids Research·R C RickertK Rajewsky
Aug 8, 1998·British Journal of Haematology·B T MortensenM T Madsen
Jan 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·I KalajzicD Rowe
Sep 18, 2003·Nature Reviews. Cancer·Gregg L Semenza
Nov 5, 2003·The Journal of Experimental Medicine·Tiziana SchioppaAntonio Sica
May 12, 2004·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M QuinteroP A Brennan
May 26, 2006·Nature·Jacques PouysségurNathalie M Mazure
Mar 22, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kalindi ParmarJulian D Down
Jan 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Xiaoyu LinYu Shen
Jul 30, 2008·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Olga S FinikovaSergei A Vinogradov
Feb 19, 2010·Cardiovascular Research·Sergio Rey, Gregg L Semenza
Mar 23, 2010·Nature·Marc H G P RaaijmakersDavid T Scadden
Jan 12, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marina Y Konopleva, Craig T Jordan
May 20, 2011·Nature Reviews. Cancer·Katherine N WeilbaecherLaurie K McCauley
Nov 24, 2011·PloS One·Enrique ZudaireSonja Vermeren
Aug 27, 2013·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Julien MazièresBarbara Klughammer
Sep 10, 2013·Cell Reports·Michael G PoulosJason M Butler
Jan 25, 2014·British Journal of Haematology·Amy L SamuelsUrsula R Kees
Feb 4, 2014·International Journal of Hematologic Oncology·Juliana BenitoWilliam R Wilson
May 23, 2014·Analytical Chemistry·Emmanuel RoussakisSergei A Vinogradov
May 3, 2015·Blood·Vincenzo GiambraAndrew P Weng
Nov 26, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Juliana BenitoMarina Konopleva
Oct 5, 2014·Bio-protocol·Kristina Y Aguilera, Rolf A Brekken

❮ Previous
Next ❯

Citations

Jul 19, 2021·Current Opinion in Chemical Biology·Martina Giampetraglia, Bettina Weigelin

❮ Previous
Next ❯

Methods Mentioned

BETA
imaging technique
phosphorescence oxygen
PCR
light microscopy
phosphorescence

Software Mentioned

GraphPad Prism
inForm
AngioTool
Imaris

Related Concepts

Related Feeds

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Metabolic Reprogramming (Keystone)

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.